Free Trial
NASDAQ:OMCL

Omnicell (OMCL) Stock Price, News & Analysis

Omnicell logo
$30.95 +0.97 (+3.24%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$30.94 -0.02 (-0.05%)
As of 10/3/2025 05:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Omnicell Stock (NASDAQ:OMCL)

Advanced

Key Stats

Today's Range
$30.12
$31.44
50-Day Range
$29.00
$33.62
52-Week Range
$22.66
$55.74
Volume
332,733 shs
Average Volume
480,001 shs
Market Capitalization
$1.42 billion
P/E Ratio
61.90
Dividend Yield
N/A
Price Target
$46.71
Consensus Rating
Hold

Company Overview

Omnicell Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
80th Percentile Overall Score

OMCL MarketRank™: 

Omnicell scored higher than 80% of companies evaluated by MarketBeat, and ranked 213th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Omnicell has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 4 buy ratings, 3 hold ratings, and 1 sell rating.

  • Upside Potential

    Omnicell has a consensus price target of $46.71, representing about 50.9% upside from its current price of $30.95.

  • Amount of Analyst Coverage

    Omnicell has only been the subject of 3 research reports in the past 90 days.

  • Read more about Omnicell's stock forecast and price target.
  • Earnings Growth

    Earnings for Omnicell are expected to grow by 13.76% in the coming year, from $1.09 to $1.24 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Omnicell is 61.90, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 233.10.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Omnicell is 61.90, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 86.96.

  • Price to Earnings Growth Ratio

    Omnicell has a PEG Ratio of 6.76. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Omnicell has a P/B Ratio of 1.15. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Omnicell's valuation and earnings.
  • Percentage of Shares Shorted

    4.29% of the outstanding shares of Omnicell have been sold short.
  • Short Interest Ratio / Days to Cover

    Omnicell has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Omnicell has recently increased by 1.55%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Omnicell does not currently pay a dividend.

  • Dividend Growth

    Omnicell does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.29% of the outstanding shares of Omnicell have been sold short.
  • Short Interest Ratio / Days to Cover

    Omnicell has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Omnicell has recently increased by 1.55%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Omnicell has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Omnicell this week, compared to 7 articles on an average week.
  • Search Interest

    2 people have searched for OMCL on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Omnicell to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Omnicell insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $129,010.00 in company stock.

  • Percentage Held by Insiders

    Only 2.52% of the stock of Omnicell is held by insiders.

  • Percentage Held by Institutions

    97.70% of the stock of Omnicell is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Omnicell's insider trading history.
Receive OMCL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Omnicell and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OMCL Stock News Headlines

Omnicell (NASDAQ:OMCL) EVP Sells $129,010.00 in Stock
Analysts Set Omnicell, Inc. (NASDAQ:OMCL) PT at $46.71
Tilson: “I’m watching HOOD”
A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fastest pace in history. CNBC calls it "the largest wealth creation spree in history." Yet 1 in 3 Americans now fear their financial situation is deteriorating. There's only one way to survive, says the man who predicted 2008 and 2020, but sadly it's already too late for many.tc pixel
Craig-Hallum Reaffirms Their Buy Rating on Omnicell (OMCL)
Omnicell names Baird Radford CFO
See More Headlines

OMCL Stock Analysis - Frequently Asked Questions

Omnicell's stock was trading at $44.52 at the beginning of the year. Since then, OMCL stock has decreased by 30.5% and is now trading at $30.95.

Omnicell, Inc. (NASDAQ:OMCL) posted its quarterly earnings data on Thursday, July, 31st. The company reported $0.45 earnings per share for the quarter, beating analysts' consensus estimates of $0.30 by $0.15. The firm's revenue for the quarter was up 5.0% on a year-over-year basis.
Read the conference call transcript
.

The following companies are subsidiaries of Omnicell: MarkeTouch Media LLC, ReCept Pharmacy, FDS Amplicare, 340B Link Business, InPharmics, Ateb Inc., Aesynt, and others.

Shares of OMCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Omnicell investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Broadcom (AVGO) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
7/31/2025
Today
10/05/2025
Next Earnings (Estimated)
10/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Health Care Technology
Current Symbol
NASDAQ:OMCL
CIK
926326
Employees
3,670
Year Founded
1992

Price Target and Rating

High Price Target
$64.00
Low Price Target
$34.00
Potential Upside/Downside
+50.9%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.50
Trailing P/E Ratio
61.90
Forward P/E Ratio
28.39
P/E Growth
6.76
Net Income
$12.53 million
Net Margins
2.01%
Pretax Margin
3.14%
Return on Equity
4.27%
Return on Assets
2.44%

Debt

Debt-to-Equity Ratio
0.13
Current Ratio
1.42
Quick Ratio
1.24

Sales & Book Value

Annual Sales
$1.11 billion
Price / Sales
1.28
Cash Flow
$3.06 per share
Price / Cash Flow
10.11
Book Value
$26.84 per share
Price / Book
1.15

Miscellaneous

Outstanding Shares
45,930,000
Free Float
44,776,000
Market Cap
$1.42 billion
Optionable
Optionable
Beta
0.88

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:OMCL) was last updated on 10/5/2025 by MarketBeat.com Staff
From Our Partners